Abstract
Colorectal cancer (CRC) is a leading cause of cancer-related death worldwide. microRNA-198 (miR-198) was reported to be a tumor suppressive miRNA but its role in CRC is largely unknown. Thus, we aimed to investigate the role of miR-198 and its downstream signaling pathway in CRC. Quantitative Real-time PCR was conducted to measure miR-198 expression in human CRC cell lines (SW620, SW480 and HT29) and normal colon cell line (FHC). Using MTT, colony formation and flow cytometry assay, we investigated the effects of miR-198 on cell proliferation, colony formation and apoptosis. Luciferase activity reporter assay and Western blot assay were performed to validate the target of miR-198. Using Western blot assay, we detected the protein levels of Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling pathway. The results showed that miR-198 expression was significantly reduced in CRC cell lines compared with FHC. Overexpression of miR-198 inhibits CRC cell proliferation and colony formation but promotes apoptosis. Further study revealed ADAM metallopeptidase domain 28 (ADAM28) was a direct target of miR-198, and the overexpression of ADAM28 reversed the effects of miR-198 on cell behaviors. Besides that, miR-198 blocks the JAK/STAT pathway through regulating ADAM28. These results collectively revealed miR-198 inhibited cell proliferation but promoted apoptosis through targeting ADAM28 and blocking JAK/STAT pathway in CRC cells.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: European review for medical and pharmacological sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.